Literature DB >> 22113444

Endothelin-1 levels in chronic congestive heart failure.

Minoru Ohmae1.   

Abstract

BACKGROUND: Endothelin-1 levels in patients with chronic congestive heart failure were evaluated with respect to the severity of cardiac dysfunction. The relationships between three neurohormones, brain natriuretic peptide (BNP), human atrial natriuretic peptide (HANP), and endothelin-1,were evaluated.
METHODS: Forty patients (17 men and 23 women, aged 64-98 years) with chronic congestive heart failure were evaluated. Echocardiography was performed for each patient, and the left ventricular ejection fraction (EF) was calculated. Titers of HANP, BNP and endothelin-1 in serum were measured. Exclusion criteria included acute myocardial infarction, unstable angina, and renal dysfunction (serum creatinine >1.6 mg/dl).
RESULTS: Endothelin-1 levels were correlated with HANP (r = 0.675, p < 0.0001) and BNP (r = 0.616, p < 0.0001) levels. Endothelin-1 levels were not correlated with the left ventricular ejection fraction or end-diastolic volume. BNP levels were correlated with the left ventricular ejection fraction (r = 0.315, p = 0.057).
CONCLUSION: These findings indicate that endothelin-1 interacts with HANP and BNP in patients with chronic congestive heart failure. Endothelin-1 is suggested to play an important role in chronic congestive heart failure with preserved ejection fraction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22113444     DOI: 10.1007/s00508-011-0097-6

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   2.275


  21 in total

1.  A sensitive sandwich-enzyme immunoassay for human endothelin.

Authors:  N Suzuki; H Matsumoto; C Kitada; T Masaki; M Fujino
Journal:  J Immunol Methods       Date:  1989-03-31       Impact factor: 2.303

2.  Stability of human atrial natriuretic peptide in blood samples.

Authors:  T Tsuji; H Masuda; K Imagawa; M Haraikawa; K Shibata; M Kono; K Inouye; K Uchida
Journal:  Clin Chim Acta       Date:  1994-03       Impact factor: 3.786

Review 3.  The cardiac fibroblast: therapeutic target in myocardial remodeling and failure.

Authors:  R Dale Brown; S Kelly Ambler; M Darren Mitchell; Carlin S Long
Journal:  Annu Rev Pharmacol Toxicol       Date:  2005       Impact factor: 13.820

4.  Endothelin stimulates accumulations of cellular atrial natriuretic peptide and its messenger RNA in rat cardiocytes.

Authors:  Y Fukuda; Y Hirata; S Taketani; T Kojima; S Oikawa; H Nakazato; Y Kobayashi
Journal:  Biochem Biophys Res Commun       Date:  1989-11-15       Impact factor: 3.575

5.  Plasma endothelin levels in hypertension and chronic renal failure.

Authors:  M Shichiri; Y Hirata; K Ando; T Emori; K Ohta; S Kimoto; M Ogura; A Inoue; F Marumo
Journal:  Hypertension       Date:  1990-05       Impact factor: 10.190

6.  Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.

Authors:  M Mukoyama; K Nakao; K Hosoda; S Suga; Y Saito; Y Ogawa; G Shirakami; M Jougasaki; K Obata; H Yasue
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

7.  Cellular mechanisms for synthesis and secretion of atrial natriuretic peptide and brain natriuretic peptide in cultured rat atrial cells.

Authors:  E Suzuki; Y Hirata; O Kohmoto; T Sugimoto; H Hayakawa; H Matsuoka; T Sugimoto; M Kojima; K Kangawa; N Minamino
Journal:  Circ Res       Date:  1992-11       Impact factor: 17.367

Review 8.  Acute neurohumoral modulation of diastolic function.

Authors:  Ricardo Ladeiras-Lopes; João Ferreira-Martins; Adelino F Leite-Moreira
Journal:  Peptides       Date:  2008-11-05       Impact factor: 3.750

9.  Cellular mechanism of natriuretic peptides-induced inhibition of endothelin-1 biosynthesis in rat endothelial cells.

Authors:  T Emori; Y Hirata; T Imai; S Eguchi; K Kanno; F Marumo
Journal:  Endocrinology       Date:  1993-12       Impact factor: 4.736

10.  Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatients.

Authors:  Christopher Adlbrecht; Martin Hülsmann; Guido Strunk; Rudolf Berger; Deddo Mörtl; Joachim Struck; Nils G Morgenthaler; Andreas Bergmann; Johannes Jakowitsch; Gerald Maurer; Irene M Lang; Richard Pacher
Journal:  Eur J Heart Fail       Date:  2009-02-03       Impact factor: 15.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.